Literature DB >> 17765639

Characteristics of DEAE-dextran-MMA graft copolymer as a nonviral gene carrier.

Yasuhiko Onishi1, Yuki Eshita, Aya Murashita, Masaaki Mizuno, Jun Yoshida.   

Abstract

A stable and soapless latex of diethylaminoethyl-dextran-methyl methacrylate (DEAE-dextran-MMA) graft copolymer (DDMC) has been developed for nonviral gene delivery vectors that are possible to autoclave. DDMC relatively easily formed a polyion complex between DNA and DDMC by the hydrophobic force of graft poly(MMA) depending on its large positive entropy change (DeltaS). DDMC has been confirmed as having a high protection facility for DNase by DNase degradation test.Transfection activity was determined using the beta-galactosidase assay, and a higher value of 16 times or more was confirmed for the DDMC samples in comparison with one of the starting DEAE-dextran hydrochloride samples. The resulting DDMC, having an amphiphilic domain so as to form a polymer micelle, should become a stable latex with a hydrophilic-hydrophobic microseparated domain. The complex of DDMC and plasmid DNA may be formed on the spherical structure of the amphiphilic microseparated domain of DDMC and have a good affinity to the cell membrane. The infrared absorption spectrum shift to a high-energy direction at around 3450 cm(-1), because of the complexes between DNA and DDMC, may cause the formation of more compact structures, not only by a coulomb force between the phosphoric acid of DNA and the DEAE group of DEAE-dextran copolymer but also by a force from the multi-intermolecule hydrogen bond in the backbone polymer DEAE-dextran and a hydrophobic force from the graft poly(MMA) in DDMC. It is thus concluded that DNA condensation may possibly have a high transfection efficiency via DDMC. The high efficiency of this graft copolymer, which is sterilized by an autoclave, may thus make it a valuable tool for safe gene delivery.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17765639     DOI: 10.1016/j.nano.2007.07.002

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  4 in total

1.  Medicinal facilities to B16F10 melanoma cells for distant metastasis control with a supramolecular complex by DEAE-dextran-MMA copolymer/paclitaxel.

Authors:  Yuki Eshita; Rui-Cheng Ji; Masayasu Onishi; Takashi Kobayashi; Masaaki Mizuno; Jun Yoshida; Naoji Kubota; Yasuhiko Onishi
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

Review 2.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

Review 3.  Anticancer efficacy of a supramolecular complex of a 2-diethylaminoethyl-dextran-MMA graft copolymer and paclitaxel used as an artificial enzyme.

Authors:  Yasuhiko Onishi; Yuki Eshita; Rui-Cheng Ji; Masayasu Onishi; Takashi Kobayashi; Masaaki Mizuno; Jun Yoshida; Naoji Kubota
Journal:  Beilstein J Nanotechnol       Date:  2014-12-01       Impact factor: 3.649

4.  Mechanism of introduction of exogenous genes into cultured cells using DEAE-dextran-MMA graft copolymer as non-viral gene carrier.

Authors:  Yuki Eshita; Junko Higashihara; Masayasu Onishi; Masaaki Mizuno; Jun Yoshida; Tomohiko Takasaki; Naoji Kubota; Yasuhiko Onishi
Journal:  Molecules       Date:  2009-07-23       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.